Erica Schwartz confirmed as CDC director, filling nearly year-long vacancy

August 5, 2026 - 18:11

The U.S. Senate has officially confirmed Erica Schwartz as the new director of the Centers for Disease Control and Prevention, ending a vacancy that stretched nearly a full year. Schwartz becomes the third person nominated for the role since President Trump began his second term, a sign of the turbulence that has marked the agency's leadership during that period.

Schwartz, a physician with a background in public health preparedness and emergency response, steps into the job at a time when the CDC is still rebuilding trust after the pandemic years. Her confirmation came after a relatively smooth committee process, though some lawmakers raised questions about her stance on vaccine policy and how she plans to handle the agency's independence from political pressure.

The vacancy had left the CDC without a permanent director for months, with deputy leaders filling the gap. That arrangement drew criticism from public health experts who argued that a lack of stable leadership hampered long-term planning and weakened the agency's voice in federal health decisions.

In her confirmation hearing, Schwartz emphasized a return to core public health functions. She spoke about strengthening disease surveillance, improving data sharing with state and local health departments, and rebuilding the CDC's workforce after a wave of resignations and retirements. She also pledged to keep the agency's scientific work transparent, while acknowledging that communication with the public needs a reset.

Schwartz takes over as the CDC faces several pressing issues, including a rise in respiratory illnesses heading into the winter season, ongoing concerns about antimicrobial resistance, and the need to modernize its aging IT infrastructure. She has not yet outlined a detailed agenda, but her early statements suggest a focus on operational basics rather than bold new initiatives.

The confirmation fills a key post in the federal health apparatus, though it remains to be seen how much autonomy Schwartz will have. Her predecessors in the role during the first Trump term often found themselves navigating between scientific recommendations and the administration's political priorities. Schwartz will likely face similar pressures, but her supporters say her experience in emergency response makes her well-suited for the job.